Neuralstem Inc (CUR :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
CUR FEATURED NEWS & ANALYSIS
MORE FROM OUR PARTNERS
-
SmithOnStocks Opines On Stocks: May 19th Edition 12 hrs ago - Seeking Alpha
-
Smaller Companies With Great Potential For Big Returns 16 May 2013 - Seeking Alpha
-
Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock 16 May 2013 - Seeking Alpha
-
Neuralstem Rounding Second With Phase II ALS Trial 16 May 2013 - Seeking Alpha
-
SmithOnStocks Opines On Recent Biotech News 13 May 2013 - Seeking Alpha
-
Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update ... 07 May 2013 - Seeking Alpha
-
StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company 02 May 2013 - Seeking Alpha
-
Stem Cells: Invest At Your Own Peril 01 May 2013 - Seeking Alpha
-
Regenerative Medicine's Time Has Come 28 Apr 2013 - Seeking Alpha
PRESS RELEASES
-
Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presente... 7 mins ago - PR Newswire
-
Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells An... 16 May 2013 - PR Newswire
-
Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I A... 13 May 2013 - PR Newswire
-
Neuralstem Reports First Quarter Financial Results And Provides Busine... 10 May 2013 - PR Newswire
-
Neuralstem ALS Trial Investigator And Patient On Sirius XM 08 May 2013 - PR Newswire
-
Research and Markets: Depression - Pipeline Review, H1 2013 Report Fea... 02 May 2013 - Business Wire
-
Research and Markets: Ischemic Stroke - Pipeline Review, H1 2013 Repor... 29 Apr 2013 - Business Wire
-
Neuralstem ALS Trial Data Presented At The American Association Of Neu... 29 Apr 2013 - PR Newswire
-
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Tria... 22 Apr 2013 - PR Newswire
